Effects of dibutyryl cyclic adenosine monophosphate on nucleolar organizer regions and epidermal growth factor receptor of dunn osteosarcoma cells

Journal of Experimental and Clinical Cancer Research

Volumn 16, Issue 2, 1997, Pages 135-139

  Kanamori, M ^a   Matsui, H ^a   Yudoh, K ^a   Maeda, A ^a   Tsuji, H ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Dibutyryl cyclic AMP; Dunn osteosarcoma cells; Epidermal growth factor receptor; Nucleolar organizer regions

Indexed keywords

BUCLADESINE; EPIDERMAL GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME NOR; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALS; BONE NEOPLASMS; BUCLADESINE; CELL DIFFERENTIATION; DNA, NEOPLASM; EPIDERMAL GROWTH FACTOR; FEMALE; IODINE RADIOISOTOPES; MICE; MICE, INBRED C3H; NUCLEOLUS ORGANIZER REGION; OSTEOSARCOMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; SILVER STAINING; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030921209     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hozumi M., Takaku F.: Differentiation of Cancer Cells and Cancer Therapy (in Japanese). Soft Science Publications. Tokyo, 1985, 1-32.
2. Freshney R.I.: Induction of differentiation in neoplastic cells. Anticancer Res. 5:111-130, 1985.
3. Hozumi M., Saito M.: Differentiation Therapy of Leukemia. Fundamentals and Clinical Trials (in Japanese). Chugai-Igaku, Tokyo, 1990, 1-9.
4. Prasad K.N., Sahu S.K., Sinha P.K.: Cyclic nucleotides in the regulation of expression of differentiated functions in neuroblastoma cells. J. Natl. Cancer Inst. 57:619-631, 1976.
5. Rupniak H.T., Rein G., Powell J.F., et al.: Characteristics of a new human neuroblastoma cell line which differentiates in response to ocyclic adenosine 3′:5′-monophosphate. Cancer Res 44: 2600-2607, 1984.
6. Chaplinski T,J., Niedel J.E.: Cyclic nucleotide-induced maturation of human promyelocytic leukemia cells. J. Clin. Invest. 70:953-964, 1982.
7. Laskin D.L., Sirak A.A., Laskin J.D.: Differentiation of HL-60 myeloid leukemia cells is associated with a transient block in the G2 phase of the cell cycle. Cell Prolif. 24:341-353, 1991.
8. Kanamori M., Matsuri H., Yudoh K., et al.: Differentiation of Dunn osteosarcoma cells in response to dibutyryl cyclic 3′-5′ - adenosine mohophosphate. J. Cancer Res. Clin. Oncol. 119: 323-328, 1993.
9. Reeves B.R., Casey G., Honeycombe J.R., Smith S.: Correlation fo differentiation state and silver staining of nucleolar organizers in the promyelocytic leukemia cell line HL-60. Cancer Genet. Cytogenet. 13:159-166, 1984.
10. Field D.H., Fitzgerald P.H., Sin F.Y.T.: Nucleolar silver-staining patterns related to cell cycle phase and cell generation of PHA-stimulated human lymphocytes. Cytobios. 41:23-33, 1984.
11. Kamata N., Chida K., Rikimaru K., Horikoshi M., Enomoto S., Kuroki T.: Growth-inhibitory effects of epidermal growth factor and over-expression of its receptors on human squamous cell carcinomas in culture. Cancer Res. 46:1648-1653, 1986.
12. Santon J.B., Cronin M.T., MacLeod C.L., Mendelsohn J., Masui H., Gill G.N.: Effects of epidermal grown factor receptor concentration on tumorigenicity of A431 cells in nude mice. Cancer Res. 46:4701-4705, 1986.
13. Dunn T.B., Anderuont H.B.: Histology of some neoplasms and nonneoplastic lesions found in wild mice maintained under laboratory conditions. J. Natl. Cancer Inst. 31;873-901, 1963.
14. Crocker J., Nar P.: Nucleolar organizer regions in Iymphomas. J. Pathol. 151:111-118, 1987.
15. Scatchard G.: The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51:660-672, 1949.
16. Sand T.E., Bronstad G., Digernes V., et al.: Quantitative aspects of the effects of insulin, epidermal growth factor and dexamethasone on DNA synthesis in cultured adult rat hepatocytes. Acta Endocrinol (Copenh) 109:369-377, 1985.
17. Salomon D.S., Perroteau I.: Growth factor in cancer and their relationship to cancer. Cancer Invest. 4:43-60, 1986.
18. Di Fiore, Pierce J.H.: Erb B-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237: 178-182, 1987.
19. Borst S.E., Catherwood B.D.: Regulation of osteosarcoma EGF receptor affinity by phorbol ester and cyclic AMP. J. Bone Miner. Res. 4:188-191, 1989.
20. Olashaw N.E., Leof E.B., O'Keefe E.J., Pledger W.J.: Differential sensitivity of fibroblasts to epidermal growth factor is related to cyclic AMP concentration. J. Cell Physiol. 118:291-297, 1984.